ImmuPharma plc (AIM:IMM)
London
· Delayed Price · Currency is GBP · Price in GBX 2.520
+0.060 (2.44%)
Jun 11, 2025, 2:31 PM GMT+1
ImmuPharma Cash Flow Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -2.48 | -2.92 | -3.81 | -8.17 | -6.86 | Upgrade
|
| Depreciation & Amortization | 0.06 | 0.04 | 0.12 | 0.11 | 0.17 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0 | 0.09 | 0 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.4 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 0.09 | 0.14 | 0.16 | 0.62 | 1.58 | Upgrade
|
| Other Operating Activities | 0.09 | 0.82 | 1.61 | 1.98 | 1.68 | Upgrade
|
| Change in Accounts Receivable | 0.21 | 0.26 | -0.3 | -0.27 | -0.01 | Upgrade
|
| Change in Accounts Payable | -0.15 | 0.21 | -0.13 | 0.9 | 0.11 | Upgrade
|
| Operating Cash Flow | -1.77 | -1.36 | -2.35 | -4.83 | -3.33 | Upgrade
|
| Capital Expenditures | -0 | - | -0.11 | -0.05 | -0.36 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.19 | - | - | - | Upgrade
|
| Investment in Securities | 1.29 | - | - | - | -0.25 | Upgrade
|
| Other Investing Activities | 0.01 | 0 | 0.03 | 0 | 0.04 | Upgrade
|
| Investing Cash Flow | 1.29 | 0.19 | -0.08 | -0.05 | -0.57 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 2.15 | Upgrade
|
| Total Debt Issued | - | - | - | - | 2.15 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -0 | -0 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -0.72 | -0.84 | Upgrade
|
| Total Debt Repaid | - | - | - | -0.72 | -0.84 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | -0.72 | 1.32 | Upgrade
|
| Issuance of Common Stock | - | 1.48 | 2.35 | 3.55 | 8 | Upgrade
|
| Other Financing Activities | 0.5 | -0.76 | -0.8 | -2.12 | -0.95 | Upgrade
|
| Financing Cash Flow | 0.5 | 0.72 | 1.55 | 0.7 | 8.37 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0 | -0.01 | -0.1 | -0.03 | 0.03 | Upgrade
|
| Net Cash Flow | 0.03 | -0.46 | -0.98 | -4.21 | 4.5 | Upgrade
|
| Free Cash Flow | -1.77 | -1.36 | -2.45 | -4.88 | -3.69 | Upgrade
|
| Free Cash Flow Margin | - | - | - | -4126.83% | -2912.91% | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.02 | -0.02 | Upgrade
|
| Cash Interest Paid | 0.01 | 0 | 0 | 0.12 | 0.06 | Upgrade
|
| Cash Income Tax Paid | -0.28 | -0.96 | -0.88 | -0.39 | -0.61 | Upgrade
|
| Levered Free Cash Flow | -1.18 | -0.99 | -1.83 | -1.79 | -1.48 | Upgrade
|
| Unlevered Free Cash Flow | -1.18 | -0.99 | -1.83 | -1.71 | -1.34 | Upgrade
|
| Change in Net Working Capital | -0.34 | -0.75 | 0.11 | -0.83 | -0.77 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.